Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.
Publication
, Journal Article
Balducci, L; Lyman, GH
Published in: J Clin Oncol
March 1, 2001
Duke Scholars
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
March 1, 2001
Volume
19
Issue
5
Start / End Page
1583 / 1585
Location
United States
Related Subject Headings
- Vincristine
- Risk Factors
- Prednisone
- Practice Guidelines as Topic
- Oncology & Carcinogenesis
- Neutropenia
- Infections
- Humans
- Granulocyte Colony-Stimulating Factor
- Doxorubicin
Citation
APA
Chicago
ICMJE
MLA
NLM
Balducci, L., & Lyman, G. H. (2001). Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol, 19(5), 1583–1585. https://doi.org/10.1200/JCO.2001.19.5.1583
Balducci, L., and G. H. Lyman. “Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.” J Clin Oncol 19, no. 5 (March 1, 2001): 1583–85. https://doi.org/10.1200/JCO.2001.19.5.1583.
Balducci L, Lyman GH. Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol. 2001 Mar 1;19(5):1583–5.
Balducci, L., and G. H. Lyman. “Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.” J Clin Oncol, vol. 19, no. 5, Mar. 2001, pp. 1583–85. Pubmed, doi:10.1200/JCO.2001.19.5.1583.
Balducci L, Lyman GH. Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol. 2001 Mar 1;19(5):1583–1585.
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
March 1, 2001
Volume
19
Issue
5
Start / End Page
1583 / 1585
Location
United States
Related Subject Headings
- Vincristine
- Risk Factors
- Prednisone
- Practice Guidelines as Topic
- Oncology & Carcinogenesis
- Neutropenia
- Infections
- Humans
- Granulocyte Colony-Stimulating Factor
- Doxorubicin